This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hangzhou Guanyu Bio-Medical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Xiaoming Yao: Innovator in Cyclic Peptide Compounds
Introduction
Xiaoming Yao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic peptide compounds. His innovative work has the potential to impact the treatment of diseases associated with histone deacetylase dysregulations.
Latest Patents
Xiaoming Yao holds a patent for a cyclic peptide compound, along with its preparation method, pharmaceutical composition, and uses. The invention is particularly noteworthy for its application in creating medicaments aimed at preventing or treating various mammalian diseases. The cyclic peptide compound is characterized by a specific structure, as indicated by general formula (I). This compound, along with its isomers, racemates, pharmaceutically acceptable salts, crystalline hydrates, solvates, or mixtures thereof, showcases a promising avenue for therapeutic development.
Career Highlights
Yao is currently associated with Hangzhou Guanyu Bio-Medical Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical sector emphasizes the importance of innovative solutions in addressing complex health issues.
Collaborations
Xiaoming Yao collaborates with notable colleagues, including Sheng Jiang and Kun Su. Their combined expertise enhances the research environment and fosters innovative approaches to drug development.
Conclusion
Xiaoming Yao's contributions to the field of cyclic peptide compounds exemplify the vital role of inventors in advancing medical science. His patent reflects a significant step forward in the preparation of effective treatments for diseases linked to histone deacetylase dysregulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile